美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Portfolio Building Block World Pharma and Biotech Index ETF

29.44

-0.1309-0.44%

盤後：29.40-0.0363-0.12%19:30 EDT

成交量：10.74萬

成交額：315.95萬

市值：10.54億

市盈率：- -

高：29.48

開：29.48

低：29.17

收：29.57

52周最高：29.82

52周最低：24.24

股本：3,580.00萬

流通股本：3,580.00萬

量比：1.39

換手率：0.30%

股息：0.02

股息率：0.08%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

GLP-1為王、專利懸崖逼近、新賽道搶跑跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

畢馬威：併購交易恢復活力年內或迎來分拆浪潮

阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/PBPH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBPH\",,,,,undefined,":{"symbol":"PBPH","market":"US","secType":"STK","nameCN":"Portfolio Building Block World Pharma and Biotech Index ETF","latestPrice":29.4363,"timestamp":1787601600000,"preClose":29.5672,"halted":0,"volume":107438,"hourTrading":{"tag":"盘后","latestPrice":29.4,"preClose":29.4363,"latestTime":"19:30 EDT","volume":8,"amount":235.381504,"timestamp":1787614207141,"change":-0.0363,"changeRate":-0.001233,"amplitude":0.001233},"delay":0,"changeRate":-0.004427203116967466,"floatShares":35800000,"shares":35800000,"eps":0,"marketStatus":"盤後交易","change":-0.1309,"latestTime":"08-24 19:44:10 EDT","open":29.48,"high":29.48,"low":29.17,"amount":3159474.067646,"amplitude":0.010485,"askPrice":44.1,"askSize":200,"bidPrice":14.7,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":29.5672,"nav":29.200848,"aum":1045390358.4,"dividendRate":0.000777,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.4,"preClose":29.4363,"latestTime":"19:30 EDT","volume":8,"amount":235.381504,"timestamp":1787614207141,"change":-0.0363,"changeRate":-0.001233,"amplitude":0.001233},"volumeRatio":1.386923},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBPH\",,,,,undefined,":{"symbol":"PBPH","floatShares":35800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.386923,"shares":35800000,"dividePrice":0.022885,"high":29.48,"amplitude":0.010485,"preClose":29.5672,"low":29.17,"week52Low":24.241,"pbRate":"--","week52High":29.82,"institutionHeld":0,"latestPrice":29.4363,"eps":0,"divideRate":0.000777,"volume":107438,"delay":0,"ttmEps":0,"open":29.48,"prevYearClose":25.2428,"prevWeekClose":29.5672,"prevMonthClose":27.19,"prevQuarterClose":27.177,"fiveDayClose":27.9294,"twentyDayClose":27.5175,"sixtyDayClose":25.8618},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBPH\",params:#limit:5,,,undefined,":[{"date":"2025-12-24","symbol":"PBPH","amount":0.022885,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Portfolio Building Block World Pharma and Biotech Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBPH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-24","recordDate":"2025-12-24","paymentDate":"2025-12-26","value":0.022885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBPH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658535936","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑 跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535936","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535936?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363243,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836820982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836820982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TRUH","APXH","BME","JDOC","FXH","BK4590","BBH","PJP","PBPH","RSPH","IYH","MEDI","IHE","BK4144","FHLC","GLP","GSKH","BBP","PPH","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641919","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641919","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641919?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:49","pubTimestamp":1786110543,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835488463.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835488463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","RSPH","JDOC","BBP","APXH","FXH","BK4144","FHLC","GLP","IYH","MEDI","BBH","PPH","PJP","PBPH","GSKH","TRUH","TMED","IHE","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657632843","title":"畢馬威：併購交易恢復活力 年內或迎來分拆浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2657632843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657632843?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 21:18","pubTimestamp":1786022287,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GTPE","IYH","BK4588","IBBQ","PEVC","UYG","CANC","XLFI","ACTV","PRVT","MMID","TBXU","PBPH","VXF","PSP","MNA","DFMC","RFG","FFSM","IEFN","TMED","RSPH","AAUM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BME","IE00BJJMRZ35.SGD","LU2596442595.SGD","LU2237443895.HKD","LU1868836591.USD","LU1093756325.SGD","LU1670710588.SGD","IE00B2B36J28.USD","LU1093756168.USD","LU2237443382.USD","IHE","FTXH","FHLC","BBH","LU0882574055.USD","LU1032466523.USD","LU0321505439.SGD","AZNH","RSPH","LU0321505868.SGD","BMY","JDOC","LU2089984988.USD","LU0868494617.USD","LU1585245621.USD","FXH","LU0225284248.USD","LU0267386448.USD","LU2242646821.SGD","LU0985481810.HKD","PPH","LU1868837300.USD","AZN","LU2462157665.USD","LU1670711123.USD","LU0128525929.USD","MEDI","LU1868836914.USD","LU0432979614.USD","BBP","AZ","IYH","BK4588","APXH","GSKH","PBPH","PJP","TRUH","BK4559","TMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBPH\",params:#limit:6,delay:false,,,undefined,":[]}}